Skip to main content

Find Clinical Trials

Home
Conditions
Apatinib

Clinical trial condition

Apatinib

Explore clinical trials studying Apatinib. Study availability and eligibility vary by location and protocol.

8 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Apatinib trial results

Recruiting

Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer

NCT03219593

Conditions: Apatinib, Biomarker, Digestive System Diseases, +8 more
Locations: Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China

View Trial Details

Recruiting

A Clinical Trial With Apatinib for Subjects With Refractory Malignant Ascites

NCT03020979

Conditions: Apatinib, Malignant Ascites
Locations: Qiong Wu Bengbu, Anhui, China

View Trial Details

Recruiting

TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma

NCT06485466

Conditions: Apatinib, Camrelizumab, Transarterial Chemoembolization, +1 more
Locations: Sichuan Cancer Hospital and Research Institute Chengdu, Sichuan, China

View Trial Details

Recruiting

Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma

NCT05512481

Conditions: Acral Melanoma, Apatinib, Camrelizumab, +15 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer

NCT07031154

Conditions: Adebrelimab, Apatinib, Bronchial Neoplasms, +10 more
Locations: First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

View Trial Details

Completed

DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma

NCT04834674

Conditions: Adenocarcinoma, Apatinib, Carcinoma, +7 more
Locations: Sichuan Cancer Hospital and Research Institute Chengdu, Sichuan, China

View Trial Details

Completed

mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer

NCT03365765

Conditions: Apatinib
Locations: Huashan Hospital Affiliated to Fudan University Shanghai, China

View Trial Details

Completed

First-line Chemotherapy for Recurrent Cervical Cancer

NCT04188847

Conditions: Apatinib, Chemotherapy, Female Urogenital Diseases, +16 more
Locations: Lei Li Beijing, Beijing Municipality, China

View Trial Details